Concepedia

Alan D. Wickenden

AD

Statistics

Publications

47

Citations

3.3K

H-Index

33

Active since

1988

Affiliations

Janssen (United States)(Current)

Johnson & Johnson (United States)

University of Toronto

Janssen (Belgium)

Toronto General Hospital

Alan D. Wickenden is an author at Janssen (United States) specializing in pharmacology, medicine, and ion channels.

Publications per year

1988–2020

47

Publications

47

Retigabine, A Novel Anti-Convulsant, Enhances Activation of KCNQ2/Q3 Potassium Channels

Alan D. Wickenden, Weifeng Yu, Anrou Zou et al. · Molecular Pharmacology · 2000 · 319 citations

, , +17

Pharmacological characterization of a novel centrally permeable <scp>P2X7</scp> receptor antagonist: <scp>JNJ</scp>‐47965567

Anindya Bhattacharya, Qi Wang, Hong Ao et al. · British Journal of Pharmacology · 2013 · 198 citations · Full text

, , +17

Modulation of Iron Uptake in Heart by L-Type Ca<sup>2+</sup>Channel Modifiers

Robert G. Tsushima, Alan D. Wickenden, Ron A. Bouchard et al. · Circulation Research · 1999 · 156 citations

, , +15

Effects of Development and Thyroid Hormone on K<sup>+</sup> Currents and K<sup>+</sup> Channel Gene Expression in Rat Ventricle

Alan D. Wickenden, Roger Kaprielian, Thomas G. Parker et al. · The Journal of Physiology · 1997 · 150 citations · Full text

, , +17

Relationship between K<sup>+</sup> channel down‐regulation and [Ca<sup>2+</sup>]<sub>i</sub> in rat ventricular myocytes following myocardial infarction

Roger Kaprielian, Alan D. Wickenden, Zamaneh Kassiri et al. · The Journal of Physiology · 1999 · 148 citations · Full text

, , +17

1–5 of 47